supported publications or other works
- A Comparison of Laparoscopically Assisted and Open Colectomy for Colon Cancer Journal Articles
- A randomized phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a quality-of-life assessment: the National Cancer Institute of Canada Clinicals Trials Group Myeloma 10 Trial Journal Articles
- ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma Journal Articles
- Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Journal Articles
- Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma Journal Articles
- Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma Journal Articles
- Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo Journal Articles
- Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27 Journal Articles
- Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer Journal Articles
- Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer Journal Articles
- Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32 Journal Articles
- Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial Journal Articles
- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial Journal Articles
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Journal Articles
- Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy Journal Articles
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors Journal Articles
- Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial Journal Articles
- Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials Journal Articles
- Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute-Sponsored Trials Journal Articles
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy Journal Articles
- Laparoscopic Colectomy for Cancer Is Not Inferior to Open Surgery Based on 5-Year Data From the COST Study Group Trial Journal Articles
- Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial Journal Articles
- Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32) Conferences
- Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor–positive breast cancer: NCIC CTG MA.27 Journal Articles
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Journal Articles
- Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer Journal Articles
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Journal Articles
- Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years Journal Articles
- Regional Nodal Irradiation in Early-Stage Breast Cancer Journal Articles
- TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial Journal Articles
-
Thalidomide‐prednisone maintenance following autologous stem cell transplant for
M ultipleM yeloma: effect on thrombin generation and procoagulant markers inNCIC CTG MY .10 Journal Articles